GLP-1
In the rapidly evolving world of GLP-1 medications, a new contender is generating significant scientific interest — not just for how much weight it helps people lose, but for what kind of weight. Pemvidutide, developed by Altimmune under the research name ALT-801, is a once-weekly injectable dual agonist of the GLP-1
Peptides
If you've spent any time in the worlds of athletic recovery, gut health, or longevity medicine, you've almost certainly encountered BPC-157. Short for Body Protection Compound 157, this 15-amino-acid peptide has generated extraordinary interest among researchers, clinicians, and biohackers alike — and for good reason. Its breadth
Peptides
Peptides
Peptides
Epithalon (Epitalon) is a tetrapeptide that activates telomerase and extends telomeres. Discover what the research shows, how to dose it, and its 2026 FDA regulatory status.
Peptides
Peptides
GLP-1
If the trajectory of weight-loss medicine over the past decade has felt like a steady upward climb, retatrutide feels like someone strapped a rocket to the ascent. Developed by Eli Lilly under the research code LY3437943, this investigational drug is the first triple-receptor agonist in clinical trials — hitting the GLP-1,
Peptides
Peptides
PT-141 (bremelanotide) is the only FDA-approved peptide that works through the brain — not blood flow — to restore sexual desire in both men and women. Here's everything you need to know.
Peptides
BPC-157 has quietly become one of the most talked-about peptides in recovery circles, functional medicine clinics, and biohacking communities worldwide. Derived from a naturally occurring protein in gastric juice, this 15-amino-acid chain has demonstrated remarkable healing properties across dozens of preclinical studies — and as of early 2026, it received a
GLP-1
Cagrilintide & CagriSema: The Amylin+GLP-1 Combo Redefining Weight Loss (2026 Guide) For years, GLP-1 receptor agonists like semaglutide and tirzepatide dominated the conversation around obesity medicine. But a new class of combination therapy is forcing experts to rethink what's possible in weight loss pharmacology. CagriSema — a once-weekly